Showing results (1-10 of 52) with videos related to
Sort By:
Pageof 6
EJIFCC|September 30, 2016
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: Emergence of the Solution to an Important Unmet NeedC E Teunissen, Eaj WillemseHandbook of Clinical Neurology|November 8, 2017
The use of cerebrospinal fluid in biomarker studiesC E Teunissen, C Verheul, E A J WillemseNeuroscience Letters|January 20, 2015
Accumulation of BRI2-BRICHOS ectodomain correlates with a decreased clearance of Aβ by insulin degrading enzyme (IDE) in Alzheimer's diseaseM Del Campo, A Stargardt, R Veerhuis, et al.Alzheimer'S Research & Therapy|May 19, 2021
A neurologist's perspective on serum neurofilament light in the memory clinic: a prospective implementation studyE A J Willemse, P Scheltens, C E Teunissen, et al.Neurobiology of Aging|May 16, 2002
Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluidC E Teunissen, J de Vente, H W M Steinbusch, et al.European Journal of Clinical Nutrition|August 25, 2005
Antioxidants and polyunsaturated fatty acids in multiple sclerosisM E van Meeteren, C E Teunissen, C D Dijkstra, et al.Multiple Sclerosis and Related Disorders|December 8, 2020
Variations in consecutive serum neurofilament light levels in healthy controls and multiple sclerosis patientsC Bridel, I M W Verberk, J J A Heijst, et al.Glia|February 5, 2009
An in vitro model for de- and remyelination using lysophosphatidyl choline in rodent whole brain spheroid culturesE J F Vereyken, D M Fluitsma, M J Bolijn, et al.Journal of Psychosomatic Research|March 30, 2016
The inflammatory marker GDF-15 is not independently associated with late-life depressionC E Teunissen, S Durieux-Lu, M A Blankenstein, et al.Journal of Neuroscience Research|April 6, 2007
24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitisC E Teunissen, S Floris, M Sonke, et al.Pageof 6